Literature DB >> 30484989

Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience

Kerollos Wanis1.   

Abstract

Background: Outcomes in liver transplantation with organs obtained via donation after cardiocirculatory death (DCD) have been suboptimal compared to donation after brain death, attributed mainly to the high incidence of ischemic cholangiopathy (IC). We evaluated the effect of a 10-year learning curve on IC rates among DCD liver graft recipients at a single centre.
Methods: We analyzed all DCD liver transplantation procedures from July 2006 to July 2016. Patients were grouped into early (July 2006 to June 2011) and late (July 2011 to July 2016) eras. Those with less than 6 months of follow-up were excluded. Primary outcomes were IC incidence and IC-free survival rate.
Results: Among the 73 DCD liver transplantation procedures performed, 70 recipients fulfilled the selection criteria, 32 in the early era and 38 in the late era. Biliary complications were diagnosed in 19 recipients (27%). Ischemic cholangiopathy was observed in 8 patients (25%) in the early era and 1 patient (3%) in the late era (p = 0.005). The IC-free survival rate was higher in the late era than the early era (98% v. 79%, p = 0.01). The warm ischemia time (27 v. 24 min, p = 0.049) and functional warm ischemia time (21 v. 17 min, p = 0.002) were significantly lower in the late era than the early era.
Conclusion: We found a significant reduction in IC rates and improvement in ICfree survival among DCD liver transplantation recipients after a learning curve period that was marked by more judicious donor selection with shorter procurement times.
© 2019 Joule Inc. or its licensors

Entities:  

Mesh:

Year:  2019        PMID: 30484989      PMCID: PMC6351268          DOI: 10.503/cjs.012017

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  32 in total

Review 1.  Donation after circulatory death.

Authors:  A R Manara; P G Murphy; G O'Callaghan
Journal:  Br J Anaesth       Date:  2012-01       Impact factor: 9.166

2.  Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors.

Authors:  C Burcin Taner; Ilynn G Bulatao; Darrin L Willingham; Dana K Perry; Lena Sibulesky; Surakit Pungpapong; Jaime Aranda-Michel; Andrew P Keaveny; David J Kramer; Justin H Nguyen
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

Review 3.  Primary graft dysfunction after liver transplantation.

Authors:  Xiao-Bo Chen; Ming-Qing Xu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2014-04

Review 4.  Preservation solutions for liver transplantation in adults: celsior versus custodiol: a systematic review and meta-analysis with an indirect comparison of randomized trials.

Authors:  G L Lema Zuluaga; R E Serna Agudelo; J J Zuleta Tobón
Journal:  Transplant Proc       Date:  2012-09-15       Impact factor: 1.066

5.  Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy.

Authors:  H Bohorquez; J B Seal; A J Cohen; A Kressel; E Bugeaud; D S Bruce; I C Carmody; T W Reichman; N Battula; M Alsaggaf; G Therapondos; N Bzowej; G Tyson; S Joshi; R Nicolau-Raducu; N Girgrah; G E Loss
Journal:  Am J Transplant       Date:  2017-04-11       Impact factor: 8.086

6.  Donation after cardiac death: the University of Wisconsin experience with liver transplantation.

Authors:  David P Foley; Luis A Fernandez; Glen Leverson; L Thomas Chin; Nancy Krieger; Jeffery T Cooper; Brian D Shames; Yolanda T Becker; Jon S Odorico; Stuart J Knechtle; Hans W Sollinger; Munci Kalayoglu; Anthony M D'Alessandro
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

7.  HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience.

Authors:  Murat T Gulsen; Mohit Girotra; Guldane Cengiz-Seval; Jennifer Price; Vikesh K Singh; Dorry L Segev; Andrew M Cameron; Ahmet Gurakar
Journal:  Ann Transplant       Date:  2013-02-20       Impact factor: 1.530

8.  The increased costs of donation after cardiac death liver transplantation: caveat emptor.

Authors:  Colleen L Jay; Vadim Lyuksemburg; Raymond Kang; Luke Preczewski; Kevin Stroupe; Jane L Holl; Michael M Abecassis; Anton I Skaro
Journal:  Ann Surg       Date:  2010-04       Impact factor: 12.969

9.  A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry.

Authors:  Colleen Jay; Daniela Ladner; Edward Wang; Vadim Lyuksemburg; Raymond Kang; Yaojen Chang; Joseph Feinglass; Jane L Holl; Michael Abecassis; Anton I Skaro
Journal:  J Hepatol       Date:  2011-02-19       Impact factor: 25.083

10.  The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story.

Authors:  Anton I Skaro; Colleen L Jay; Talia B Baker; Edward Wang; Sarina Pasricha; Vadim Lyuksemburg; John A Martin; Joseph M Feinglass; Luke B Preczewski; Michael M Abecassis
Journal:  Surgery       Date:  2009-10       Impact factor: 3.982

View more
  2 in total

1.  Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2021 Abstracts.

Authors: 
Journal:  Can Liver J       Date:  2021-04-29

Review 2.  Addressing organ shortages: progress in donation after circulatory death for liver transplantation

Authors:  Jordan J. Nostedt; James Shapiro; Darren H. Freed; David L. Bigam
Journal:  Can J Surg       Date:  2020-03-20       Impact factor: 2.089

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.